Compare Freshworks Inc (FRSH) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freshworks Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Freshworks Inc trades at $13.92 (market cap $3.56B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Freshworks Inc is the larger of the two by market cap, and Freshworks Inc is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| FRSH | SLS | |
|---|---|---|
Market Cap | $3.56B | $2.27B |
Volume | 9,066,454 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $13.92 | $15.46 |
52-Week Low | $6.88 | $1.39 |
Typical Hold Time | 39 Days | — |
Enterprise Value | $2.93B | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Freshworks (FRSH) trades at $13.64, up 0.29% on the day, with a bullish technical signal and strong fundamental momentum. The company achieved its first quarter of GAAP profitability in Q2 2026, beating earnings expectations with $0.17 EPS versus $0.13 expected. Revenue growth remains robust at 16% year-over-year, supported by a high gross margin of 84.96%. Analyst sentiment is evenly split between Buy and Hold, with a consensus price target of $14.60.
The outlook for FRSH is positive, driven by sustained revenue growth, improving profitability, and strategic focus on AI and enterprise solutions. Key risks include competitive pressures in the SaaS sector and execution challenges in maintaining growth momentum. The stock presents an opportunity for upside relative to the consensus target, but investors should monitor quarterly execution against elevated expectations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
